In a laboratory study using an experimental peritoneum model of gastrointestinal cancer, the UFTP [tegafur and uracil (UFT) plus cisplatin] regimen was shown to provide a survival benefit compared with the UFTM (UFT plus
Minoru Kurihara, MD
Advertisement
Articles by Minoru Kurihara, MD
Advertisement
Latest Updated Articles
- UFT Plus Cisplatin for Advanced Gastric Cancer
September 2nd 1997
Advertisement
Advertisement
Trending on CancerNetwork
1
Data Readouts to Watch at the 2026 ASCO Annual Meeting
2
Alpha DaRT Elicits 100% Local Disease Control in Pancreatic Cancer
3
Outlining Exercise as a “Biologically Interventional Therapy” for Cancer
4
Navigating The Dynamic Landscape of Stem Cell Transplantation
5